Skip to main content
Blackhawk Growth Corp. logo

Blackhawk Growth Corp. — Investor Relations & Filings

Ticker · BLR ISIN · CA09238B3083 LEI · 875500A5R3SVGXL39M70 CSE Financial and insurance activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2022-05-11 Regulatory Filings
Country CA Canada
Listing CSE BLR

About Blackhawk Growth Corp.

https://www.blackhawkgrowthcorp.com/

Blackhawk Growth Corp. operates as an investment issuer, specializing in generating shareholder value through strategic investments in the technology and life sciences sectors. The company focuses on acquiring and developing assets, intellectual property, and projects related to medical technologies, pharmaceuticals, digital health, software, big data, and AI. Blackhawk seeks opportunities that demonstrate global scalability and potential for positive impact on health and human wellbeing. Its core strategy involves providing capital for R&D and commercialization, followed by value realization through mergers, acquisitions, divestments, or spin-outs and public listings on North American stock exchanges.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2022-05-11 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 Material Change Report' and details a material change event regarding Blackhawk Growth Corp.'s subsidiary MindBio Therapeutics completing a Phase 1 clinical trial. It includes a summary of the material change, a full description, and contact information for the CEO. The document is a regulatory filing reporting a material change event, not a full financial report or earnings release. It is not an announcement of a report publication but the actual material change report itself. This fits the category of Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit into more specific categories like earnings release or annual report.
2022-05-03 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the completion of a Phase 1 clinical trial by MindBio Therapeutics, a subsidiary of Blackhawk Growth Corp. It highlights the successful completion of the trial, the uniqueness of the trial, and future plans including Phase 2 trials and a spin-out. There are no detailed financial statements, regulatory filings, or comprehensive report data included. The document is an announcement of a milestone event rather than a full report or detailed financial disclosure. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a corporate announcement about clinical trial progress and company plans, which aligns best with a general Regulatory Filing (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2022-05-03 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Material Change Report' and references Form 51-102F3, which is a regulatory filing used in Canadian securities regulation to disclose material changes in a company. The content describes a completed investment transaction by Blackhawk Growth Corp., including details of the acquisition and share issuance. It is not an annual or quarterly financial report, nor is it an earnings release or management discussion. It is a specific regulatory announcement about a material change event. The document length is 4089 characters, which is relatively short but contains substantive information about the material change itself, not just a notice of report publication. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories like capital update or M&A filings (which are more detailed merger/takeover documents).
2022-04-28 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the completion of an investment transaction where Blackhawk Growth Corp. acquired all outstanding shares of Blum Distributors Ltd. It details the issuance of shares as consideration, confirms no change of control, and provides background information on both companies. There is no financial statement, regulatory certification, or detailed financial analysis present. The document is an announcement of a capital investment transaction rather than a full financial report or regulatory filing. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 4923 characters, which is consistent with a typical announcement rather than a full report.
2022-04-28 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2022-04-21 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.